These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28392299)

  • 1. Corrigendum to "Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy" [Parkinsonism Relat. Disord. 35 (2017) 88-91].
    Goldstein DS; Sullivan P; Holmes C; Mash DC; Kopin IJ; Sharabi Y
    Parkinsonism Relat Disord; 2017 Jun; 39():95. PubMed ID: 28392299
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes" [Parkinsonism Relat. Disord. 21(3) (2015) 231-235].
    Antonini A; Yegin A; Preda C; Bergmann L; Poewe W;
    Parkinsonism Relat Disord; 2016 Oct; 31():162. PubMed ID: 27575745
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study" [Park. Relat. Disord. 28 (2016) 49-55].
    Zhang ZX; Shang HF; Hu X; Chen S; Zhao Z; Du X; Surmann E; Bauer L; Asgharnejad M
    Parkinsonism Relat Disord; 2017 May; 38():108. PubMed ID: 28258926
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy.
    Perju-Dumbrava LD; Kovacs GG; Pirker S; Jellinger K; Hoffmann M; Asenbaum S; Pirker W
    Mov Disord; 2012 Jan; 27(1):65-71. PubMed ID: 22102521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Risk of Parkinson's disease-related death in cancer survivors: A population-based study in Japan" [Park. Relat. Disord. 119 (2024) 105966].
    Hayano E; Gon Y; Kimura Y; Zha L; Morishima T; Ohno Y; Mochizuki H; Sobue T; Miyashiro I
    Parkinsonism Relat Disord; 2024 Mar; 120():105990. PubMed ID: 38211434
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease" [Parkinsonism Relat. Disord. 25C (2016) 58-64].
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Oct; 31():161. PubMed ID: 27567724
    [No Abstract]   [Full Text] [Related]  

  • 8. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Prevalence and functional impact of parkinsonian signs in older adults from the Good Aging in Skåne study" [Parkinsonism Relat. Disord. 111 (2023)].
    Algotsson C; Rosso A; Elmståhl S; Siennicki-Lantz A
    Parkinsonism Relat Disord; 2023 Aug; 113():105485. PubMed ID: 37308400
    [No Abstract]   [Full Text] [Related]  

  • 10. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study" [Park. Relat. Disord. (2024) 106993].
    Cámara A; Compta Y; Baixauli M; Maragall L; Pérez-Soriano A; Montagut N; Ahuir M; Ludeña E; Peri L; Fernández N; Villote S; Lopez de Los Reyes JC; Navarro-Otano J; Zaro I; Muñoz E; Buongiorno M; Caballol N; Pont-Sunyer C; Puente V; Giraldo D; Valldeoriola F; Lombraña M; Martí MJ
    Parkinsonism Relat Disord; 2024 Oct; 127():107059. PubMed ID: 39146661
    [No Abstract]   [Full Text] [Related]  

  • 12. The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy.
    De Cock VC; Debs R; Oudiette D; Leu S; Radji F; Tiberge M; Yu H; Bayard S; Roze E; Vidailhet M; Dauvilliers Y; Rascol O; Arnulf I
    Brain; 2011 Mar; 134(Pt 3):856-62. PubMed ID: 21310729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report.
    Ishibashi K; Nishina H; Ishiwata K; Ishii K
    BMC Res Notes; 2015 Sep; 8():496. PubMed ID: 26419749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic resonance imaging of parkinsonism].
    Mukai E; Makino N; Fujishiro K
    Rinsho Shinkeigaku; 1989 Jun; 29(6):720-5. PubMed ID: 2582685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
    Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
    J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease.
    Scherfler C; Seppi K; Mair KJ; Donnemiller E; Virgolini I; Wenning GK; Poewe W
    Brain; 2012 Nov; 135(Pt 11):3348-54. PubMed ID: 23043142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.